[English] 日本語
Yorodumi
- PDB-4rjf: Crystal structure of the human sliding clamp at 2.0 angstrom reso... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 4rjf
TitleCrystal structure of the human sliding clamp at 2.0 angstrom resolution
Components
  • Cyclin-dependent kinase inhibitor 1
  • Proliferating cell nuclear antigen
KeywordsREPLICATION / sliding clamp / processivity factor / p21 / DNA polymerase / Nucleus
Function / homology
Function and homology information


cyclin-dependent protein kinase activating kinase activity / cellular response to cell-matrix adhesion / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / FOXO-mediated transcription of cell cycle genes / TFAP2 (AP-2) family regulates transcription of cell cycle factors / positive regulation of deoxyribonuclease activity / dinucleotide insertion or deletion binding / PCNA-p21 complex / mitotic telomere maintenance via semi-conservative replication ...cyclin-dependent protein kinase activating kinase activity / cellular response to cell-matrix adhesion / negative regulation of cyclin-dependent protein kinase activity / negative regulation of cardiac muscle tissue regeneration / FOXO-mediated transcription of cell cycle genes / TFAP2 (AP-2) family regulates transcription of cell cycle factors / positive regulation of deoxyribonuclease activity / dinucleotide insertion or deletion binding / PCNA-p21 complex / mitotic telomere maintenance via semi-conservative replication / intestinal epithelial cell maturation / purine-specific mismatch base pair DNA N-glycosylase activity / negative regulation of phosphorylation / MutLalpha complex binding / positive regulation of DNA-directed DNA polymerase activity / regulation of cell cycle G1/S phase transition / nuclear lamina / tissue regeneration / Transcriptional regulation by RUNX2 / Polymerase switching / Telomere C-strand (Lagging Strand) Synthesis / Processive synthesis on the lagging strand / PCNA complex / Removal of the Flap Intermediate / negative regulation of DNA biosynthetic process / Processive synthesis on the C-strand of the telomere / cyclin-dependent protein serine/threonine kinase inhibitor activity / Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) / Polymerase switching on the C-strand of the telomere / Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) / replisome / response to arsenic-containing substance / Transcription of E2F targets under negative control by DREAM complex / Removal of the Flap Intermediate from the C-strand / Transcriptional activation of cell cycle inhibitor p21 / positive regulation of programmed cell death / oncogene-induced cell senescence / RUNX3 regulates CDKN1A transcription / AKT phosphorylates targets in the cytosol / stress-induced premature senescence / DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator / response to L-glutamate / : / response to corticosterone / response to aldosterone / cellular response to UV-B / histone acetyltransferase binding / negative regulation of G1/S transition of mitotic cell cycle / regulation of cyclin-dependent protein serine/threonine kinase activity / molecular function inhibitor activity / leading strand elongation / DNA polymerase processivity factor activity / STAT5 activation downstream of FLT3 ITD mutants / G1/S-Specific Transcription / p53-Dependent G1 DNA Damage Response / protein kinase inhibitor activity / response to dexamethasone / replication fork processing / nuclear replication fork / Constitutive Signaling by AKT1 E17K in Cancer / Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) / mitotic G2 DNA damage checkpoint signaling / regulation of G1/S transition of mitotic cell cycle / negative regulation of vascular associated smooth muscle cell proliferation / SUMOylation of DNA replication proteins / keratinocyte proliferation / response to X-ray / replicative senescence / PCNA-Dependent Long Patch Base Excision Repair / positive regulation of protein kinase activity / intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator / estrous cycle / response to hyperoxia / animal organ regeneration / mismatch repair / translesion synthesis / TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest / Regulation of MITF-M-dependent genes involved in cell cycle and proliferation / response to cadmium ion / Cyclin E associated events during G1/S transition / DNA polymerase binding / cyclin-dependent protein kinase holoenzyme complex / Cyclin A:Cdk2-associated events at S phase entry / positive regulation of B cell proliferation / epithelial cell differentiation / keratinocyte differentiation / base-excision repair, gap-filling / regulation of G2/M transition of mitotic cell cycle / DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest / protein sequestering activity / Signaling by FLT3 fusion proteins / intrinsic apoptotic signaling pathway / cellular response to amino acid starvation / positive regulation of DNA repair / cyclin binding / negative regulation of protein phosphorylation / Translesion synthesis by REV1 / Translesion synthesis by POLK / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / Translesion synthesis by POLI
Similarity search - Function
Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Box / Proliferating Cell Nuclear Antigen / Proliferating Cell Nuclear Antigen - #10 / Proliferating cell nuclear antigen signature 2. / Proliferating cell nuclear antigen, PCNA, conserved site / Proliferating cell nuclear antigen signature 1. ...Cyclin-dependent kinase inhibitor 1 / Cyclin-dependent kinase inhibitor domain / Cyclin-dependent kinase inhibitor domain superfamily / Cyclin-dependent kinase inhibitor / Box / Proliferating Cell Nuclear Antigen / Proliferating Cell Nuclear Antigen - #10 / Proliferating cell nuclear antigen signature 2. / Proliferating cell nuclear antigen, PCNA, conserved site / Proliferating cell nuclear antigen signature 1. / Proliferating cell nuclear antigen, PCNA / Proliferating cell nuclear antigen, PCNA, N-terminal / Proliferating cell nuclear antigen, PCNA, C-terminal / Proliferating cell nuclear antigen, N-terminal domain / Proliferating cell nuclear antigen, C-terminal domain / : / Alpha Beta
Similarity search - Domain/homology
Proliferating cell nuclear antigen / Cyclin-dependent kinase inhibitor 1
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2.0072 Å
AuthorsKroker, A.J. / Bruning, J.B.
CitationJournal: Biochemistry / Year: 2015
Title: p21 Exploits Residue Tyr151 as a Tether for High-Affinity PCNA Binding.
Authors: Kroker, A.J. / Bruning, J.B.
History
DepositionOct 9, 2014Deposition site: RCSB / Processing site: RCSB
Revision 1.0Aug 26, 2015Provider: repository / Type: Initial release
Revision 1.1Sep 20, 2023Group: Data collection / Database references / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model / struct_ref_seq_dif
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _struct_ref_seq_dif.details
Revision 1.2Oct 30, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Proliferating cell nuclear antigen
B: Cyclin-dependent kinase inhibitor 1
C: Proliferating cell nuclear antigen
D: Cyclin-dependent kinase inhibitor 1
E: Proliferating cell nuclear antigen
F: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)94,6776
Polymers94,6776
Non-polymers00
Water34,7151927
1
A: Proliferating cell nuclear antigen
B: Cyclin-dependent kinase inhibitor 1

A: Proliferating cell nuclear antigen
B: Cyclin-dependent kinase inhibitor 1

A: Proliferating cell nuclear antigen
B: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)94,6776
Polymers94,6776
Non-polymers00
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_675-y+1,x-y+2,z1
crystal symmetry operation3_465-x+y-1,-x+1,z1
2
C: Proliferating cell nuclear antigen
D: Cyclin-dependent kinase inhibitor 1

C: Proliferating cell nuclear antigen
D: Cyclin-dependent kinase inhibitor 1

C: Proliferating cell nuclear antigen
D: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)94,6776
Polymers94,6776
Non-polymers00
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_775-y+2,x-y+2,z1
crystal symmetry operation3_575-x+y,-x+2,z1
3
E: Proliferating cell nuclear antigen
F: Cyclin-dependent kinase inhibitor 1

E: Proliferating cell nuclear antigen
F: Cyclin-dependent kinase inhibitor 1

E: Proliferating cell nuclear antigen
F: Cyclin-dependent kinase inhibitor 1


Theoretical massNumber of molelcules
Total (without water)94,6776
Polymers94,6776
Non-polymers00
Water1086
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation2_665-y+1,x-y+1,z1
crystal symmetry operation3_565-x+y,-x+1,z1
Unit cell
Length a, b, c (Å)142.970, 142.970, 41.410
Angle α, β, γ (deg.)90.00, 90.00, 120.00
Int Tables number143
Space group name H-MP3

-
Components

#1: Protein Proliferating cell nuclear antigen / PCNA / Cyclin


Mass: 28795.752 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: PCNA / Plasmid: pMCSG19 / Production host: Escherichia coli (E. coli) / Strain (production host): BL21(DE3) / References: UniProt: P12004
#2: Protein/peptide Cyclin-dependent kinase inhibitor 1 / CDK-interacting protein 1 / Melanoma differentiation-associated protein 6 / MDA-6 / p21


Mass: 2763.233 Da / Num. of mol.: 3 / Fragment: 22 C TERMINAL RESIDUES (139 - 160) / Mutation: Y151F / Source method: obtained synthetically / Details: p21 peptide chemically synthesized / Source: (synth.) Homo sapiens (human) / References: UniProt: P38936
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 1927 / Source method: isolated from a natural source / Formula: H2O
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.58 Å3/Da / Density % sol: 52.34 %
Crystal growTemperature: 289 K / Method: vapor diffusion, sitting drop / pH: 7
Details: 0.08M strontium chloride hexahydrate, 0.02M magnesium chloride hexahydrate, 0.04M sodium cacodylate trihydrate (pH7.0), 20% v/v (+/-)-2-methyl-2,4-pentanediol and 0.012M spermine ...Details: 0.08M strontium chloride hexahydrate, 0.02M magnesium chloride hexahydrate, 0.04M sodium cacodylate trihydrate (pH7.0), 20% v/v (+/-)-2-methyl-2,4-pentanediol and 0.012M spermine tetrahydrochloride, final [PCNA] = 11.6mg/mL = 0.40mM, VAPOR DIFFUSION, SITTING DROP, temperature 289K

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: ROTATING ANODE / Type: RIGAKU MICROMAX-007 HF / Wavelength: 1.5418 Å
DetectorType: RIGAKU RAXIS IV++ / Detector: IMAGE PLATE / Date: Jul 22, 2014 / Details: mirrors
RadiationMonochromator: Rigaku VariMax HF mirrors / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.5418 Å / Relative weight: 1
Reflection twinOperator: -h,-k,l / Fraction: 0.49
ReflectionResolution: 2.0072→41.41 Å / Num. all: 63388 / Num. obs: 63388 / % possible obs: 100 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / Redundancy: 7.1 % / Biso Wilson estimate: 28.6 Å2 / Rmerge(I) obs: 0.055 / Rsym value: 0.055 / Net I/σ(I): 25 / Scaling rejects: 1365
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsMean I/σ(I) obsNum. measured allNum. unique all% possible all
2.0072-2.066.40.4493.828350444499.9
9.19-41.417.40.02483.8487965898.9

-
Phasing

PhasingMethod: molecular replacement
Phasing MRModel details: Phaser MODE: MR_AUTO
Highest resolutionLowest resolution
Rotation2.01 Å39.27 Å
Translation2.01 Å39.27 Å

-
Processing

Software
NameVersionClassificationNB
MOSFLMdata reduction
Aimless0.1.27data scaling
PHASER2.5.1phasing
PHENIXrefinement
PDB_EXTRACT3.15data extraction
CrystalCleardata collection
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 1AXC

1axc


Resolution: 2.0072→39.272 Å / Isotropic thermal model: isotropic / Cross valid method: THROUGHOUT / σ(F): 1.98 / σ(I): 0 / Phase error: 20.77 / Stereochemistry target values: TWIN_LSQ_F
RfactorNum. reflection% reflectionSelection details
Rfree0.1887 1976 3.12 %random
Rwork0.1478 ---
all0.1546 63385 --
obs0.1546 63385 99.98 %-
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 47.97 Å2 / Biso mean: 26.152 Å2 / Biso min: 13.38 Å2
Refinement stepCycle: LAST / Resolution: 2.0072→39.272 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms6250 0 0 1927 8177
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0026358
X-RAY DIFFRACTIONf_angle_d0.6318566
X-RAY DIFFRACTIONf_chiral_restr0.0251007
X-RAY DIFFRACTIONf_plane_restr0.0031093
X-RAY DIFFRACTIONf_dihedral_angle_d12.8482375
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Total num. of bins used: 14 / % reflection obs: 97 %

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all
2.0072-2.05740.30631460.214943904536
2.0574-2.11290.25361400.200343674507
2.1129-2.1750.25321410.195144244565
2.175-2.24510.21761400.185643034443
2.2451-2.32530.27251460.180144104556
2.3253-2.41820.20381380.178243854523
2.4182-2.52810.26121390.169343484487
2.5281-2.66110.17361400.164743884528
2.6611-2.82730.181390.161243844523
2.8273-3.04490.21641400.150843864526
3.0449-3.35010.16271430.143843424485
3.3501-3.83180.18621390.137143984537
3.8318-4.81630.17141360.120643714507
4.8163-19.88860.14961490.138843834532

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more